InvestorsHub Logo
Followers 167
Posts 11460
Boards Moderated 3
Alias Born 03/08/2008

Re: None

Thursday, 12/01/2011 11:19:14 PM

Thursday, December 01, 2011 11:19:14 PM

Post# of 3360
Webcast highlights........ 150 million dollars in possible revenue to Isoray with new products and in new markets.90 to 120 days for approval of liquid cesium131. Working on catheter for breast cancer treatment. Cash flow positive by end of 2012. No new cash needed and feels current cash on hand is plenty to get Isoray to end of 2012 when they will be cash flow positive. Perfectly positioned for OBAMACARE - Isoray cesium131 @ 12 k cost of treatment compaired to 50k for external treatments.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CATX News